ACLLY vs. AZN
ACLLY (Accelleron Industries AG ADR) and AZN (AstraZeneca PLC) are both stocks. ACLLY operates in Aerospace & Defense (Industrials), while AZN operates in Drug Manufacturers - General (Healthcare). Over the past 3 years, ACLLY returned 69.19%/yr vs 9.46%/yr for AZN. At a 0.10 correlation, their price movements are largely independent.
Performance
ACLLY vs. AZN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ACLLY achieves a 38.92% return, which is significantly higher than AZN's -2.03% return.
ACLLY
- 1D
- 2.91%
- 1M
- 5.47%
- YTD
- 38.92%
- 6M
- 37.00%
- 1Y
- 60.50%
- 3Y*
- 69.19%
- 5Y*
- —
- 10Y*
- —
AZN
- 1D
- 0.86%
- 1M
- -5.67%
- YTD
- -2.03%
- 6M
- -1.63%
- 1Y
- 29.64%
- 3Y*
- 9.46%
- 5Y*
- 11.29%
- 10Y*
- 15.57%
ACLLY vs. AZN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
ACLLY Accelleron Industries AG ADR | 38.92% | 56.70% | 69.48% | 60.55% | 2.00% |
AZN AstraZeneca PLC | -2.03% | 43.30% | -0.62% | 1.44% | 22.05% |
Correlation
The correlation between ACLLY and AZN is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Oct 4, 2022 | 0.10 |
The correlation between ACLLY and AZN shifts across timeframes, from -0.01 (1 year) to 0.10 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ACLLY:
$9.98B
AZN:
$275.41B
ACLLY:
$4.29
AZN:
$6.66
ACLLY:
24.79
AZN:
26.51
ACLLY:
1.29
AZN:
0.04
ACLLY:
4.37
AZN:
4.56
ACLLY:
20.91
AZN:
5.82
ACLLY:
$2.28B
AZN:
$60.44B
ACLLY:
$1.02B
AZN:
$49.37B
ACLLY:
$569.11M
AZN:
$20.47B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ACLLY vs. AZN — Risk / Return Rank
ACLLY
AZN
ACLLY vs. AZN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Accelleron Industries AG ADR (ACLLY) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACLLY | AZN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.67 | ||
| Sortino ratioReturn per unit of downside risk | +0.73 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.22 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 3.18 | 1.86 | +1.32 |
| Martin ratioReturn relative to average drawdown | 5.83 | 4.92 | +0.92 |
Loading charts...
Drawdowns
ACLLY vs. AZN - Drawdown Comparison
The maximum ACLLY drawdown since its inception was -30.00%, smaller than the maximum AZN drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for ACLLY and AZN.
Loading charts...
Drawdown Indicators
| ACLLY | AZN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.00% | -48.94% | +18.94% |
Max Drawdown (1Y)Largest decline over 1 year | -19.13% | -16.08% | -3.05% |
Max Drawdown (3Y)Largest decline over 3 years | -28.69% | -27.87% | -0.82% |
Max Drawdown (5Y)Largest decline over 5 years | — | -27.87% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -27.87% | — |
Current DrawdownCurrent decline from peak | -7.54% | -15.36% | +7.82% |
Average DrawdownAverage peak-to-trough decline | -5.84% | -11.37% | +5.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.41% | 6.06% | +4.35% |
Volatility
ACLLY vs. AZN - Volatility Comparison
Accelleron Industries AG ADR (ACLLY) has a higher volatility of 9.10% compared to AstraZeneca PLC (AZN) at 7.60%. This indicates that ACLLY's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ACLLY | AZN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.10% | 7.60% | +1.50% |
Volatility (6M)Calculated over the trailing 6-month period | 26.70% | 17.62% | +9.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.06% | 25.53% | +7.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 41.05% | 24.07% | +16.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.05% | 24.92% | +16.13% |
Dividends
ACLLY vs. AZN - Dividend Comparison
ACLLY's dividend yield for the trailing twelve months is around 1.77%, less than AZN's 3.02% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACLLY Accelleron Industries AG ADR | 1.77% | 1.94% | 2.95% | 4.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AZN AstraZeneca PLC | 3.02% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
Financials
ACLLY vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between Accelleron Industries AG ADR and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ACLLY vs. AZN - Profitability Comparison
ACLLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Accelleron Industries AG ADR reported a gross profit of 287.36M and revenue of 654.31M. Therefore, the gross margin over that period was 43.9%.
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.
ACLLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Accelleron Industries AG ADR reported an operating income of 159.35M and revenue of 654.31M, resulting in an operating margin of 24.4%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.
ACLLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Accelleron Industries AG ADR reported a net income of 123.09M and revenue of 654.31M, resulting in a net margin of 18.8%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.
Frequently Asked Questions
ACLLY and AZN have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ACLLY has higher volatility (9.10%) compared to AZN (7.60%). In terms of maximum drawdown, ACLLY dropped -30.00% vs AZN's -48.94%.
ACLLY currently has the higher Sharpe Ratio (1.84 vs 1.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ACLLY and AZN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer